3SBIO News

3SBIO: (1) FURTHER EXTENSION OF FACILITY AGREEMENT (2) COMPLETION OF REDEMPTION OF CONVERTIBLE BONDS PURSUANT TO EXERCISE OF PUT OPTION BY BONDHOLDERS

Jul 17, 2023 10:47 ET

3SBIO: BUSINESS UPDATE - TERMINATION OF EXCLUSIVE LICENSE AGREEMENT WITH ASTRAZENECA IN RESPECT OF BYETTA AND BYDUREON

Feb 28, 2023 08:45 ET

3SBIO: DISCLOSEABLE TRANSACTION - SUBSCRIPTIONS OF WEALTH MANAGEMENT PRODUCTS

Sep 20, 2022 10:54 ET

3SBIO: (1) FURTHER EXTENSION OF FACILITY AGREEMENT AND (2) CHANGE OF COMPANY SECRETARY, AUTHORIZED REPRESENTATIVE AND PROCESS AGENT

Jul 18, 2021 06:12 ET

3SBIO: BUSINESS UPDATE - EXCLUSIVE LICENSE AGREEMENT WITH ASTRAZENECA IN RESPECT OF BYETTA AND BYDUREON

Feb 5, 2021 08:31 ET

3SBIO: DELAY IN DESPATCH OF CIRCULAR

Oct 9, 2020 08:11 ET

3SBIO: FURTHER EXTENSION OF FACILITY AGREEMENT

Jul 17, 2020 09:28 ET

3SBIO: ADOPTION OF EMPLOYEE SHARE OWNERSHIP PLAN AND GRANT OF AWARDED SHARES BY A SUBSIDIARY OF THE COMPANY

Jul 1, 2019 20:24 ET